Latest News
November 16, 2021
Two Yale Department of Psychiatry researchers have been awarded a $2 million grant from The Michael J. Fox Foundation for Parkinson’s Research to conduct the first clinical trial of ketamine to treat depression in people with Parkinson’s disease.